Managing Myeloma
- 2012-10-02 - The Multiple Myeloma Drug Market Will Experience Significant Growth, Increasing from $4.4 Billion in 2011 to $7.2 Billion in 2021 -- Market Watch:The Wall Street Journal
- 2012-10-01 - Researchers harness the immune system to improve stem cell transplant outcomes
- 2012-09-08 - Balloons Carve Spot in Myeloma Spine Disease - IMNE
- 2012-08-16 - Novel Therapeutic Approach to Cancer Treatment: Senesco completes first cohort of patients in Phase 1b/2a multiple myeloma trial -- PBR
- 2012-08-15 - Longtime biotech exec Richard Brewer dies from multiple myeloma--San Francisco Business Times
- 2012-08-14 - Scientists devise new strategy to destroy multiple myeloma -- Science Codex
- 2012-08-06 - Cancer Patients Differ With Docs on QoL Issues- The Oncology Report
- 2012-08-06 - Experts Assess Impact of Carfilzomib Approval - Pharmacy Practice News
- 2012-07-25 - Onyx Pharmaceuticals Announces Carfilzomib Study Published in the Medical Journal Blood- PRNewswire
- 2012-07-23 - Bortezomib Ups Response, Survival in Multiple Myeloma-Doctor's Lounge
- 2012-07-20 - FDA Approves Carfilzomib for Some Patients with Multiple Myeloma- FDA News
- 2012-06-20 - Live Coverage Of The Carfilzomib FDA Advisory Committee Meeting- Meeting Scheduled for 1pm EDT -- Myeloma Beacon
- 2012-06-20 - Carfilzomib Combo Achieves High Response in Multiple Myeloma -- Medscape News
- 2012-06-20 - FDA Panel Gives Nod to Novel Myeloma Drug [Carfilzomib] - MedPage Today
- 2012-06-19 - Lenalidomide use in frontline multiple myeloma faces EU payor resistance without overall survival data -- Financial Times